Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Unit Trust
  • Objective: Technology Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Allianz Global Investors Global Biotech Fund

+ Add to Watchlist

DREGBIO:TT

40.51 TWD 0.03 0.07%

As of 09:58:00 ET on 05/21/2015.

Snapshot for Allianz Global Investors Global Biotech Fund (DREGBIO)

Year To Date: +12.31% 3-Month: +8.32% 3-Year: +35.76% 52-Week Range: 28.27 - 42.24
1-Month: -0.05% 1-Year: +48.12% 5-Year: +26.50% Beta vs TWSE: 0.70

Mutual Fund Chart for DREGBIO

No chart data available.
  • DREGBIO:TT 40.51
  • 1M
  • 1Y
Interactive DREGBIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DREGBIO

Allianz Global Investors Global Biotech Fund is an open-end unit trust establish ed in Taiwan. The Fund's objective is to seek long-term capital gain and secure stable income. The Fund invests primarily in equity securities issued by companies in the biotechnology sector. It also invests in local equities and government bonds (including convertibles) and financial debentures.

Inception Date: 06-28-2002 Telephone: 886-2-2502-8889
Managers: FU TZU-PING "MARK"
Web Site: www.allianzglobalinvestors.com.tw

Fundamentals for DREGBIO

NAV (on 2015-05-21) 40.51
Assets (M) (on 2015-04-30) 4,913.49
Fund Leveraged N
Minimum Investment 10,000.00
Minimum Subsequent Investment 3,000.00

Dividends for DREGBIO

No dividends reported

Fees & Expenses for DREGBIO

Front Load 2.00
Back Load 0.00
Current Mgmt Fee 1.80
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for DREGBIO

Filing Date: 03/31/2014
Name Position Value % of Total
Alexion Pharmaceuticals Inc 68,618 317,908,899 7.700%
Biogen Inc 30,051 279,924,979 6.780%
Regeneron Pharmaceuticals Inc 24,650 225,426,310 5.460%
Protalix BioTherapeutics Inc 1,352,752 188,680,996 4.570%
Gilead Sciences Inc 85,521 184,552,309 4.470%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil